ClearRead technology is the first FDA-cleared AI system that improves both detection and reading time for lung abnormalities. For better outcomes and efficiency, the difference is clear.
"*" indicates required fields
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
ClearRead technology is the first FDA-cleared AI system that improves both detection and reading time for lung abnormalities. For better outcomes and efficiency, the difference is clear.
Detecting lung cancer using traditional CT studies and XRs can be complicated by a myriad of obstacles, including: bones (XR) and vessels (CT); device variation; and acquisition effects. Our technology is FDA cleared, CE marked, and clinically proven across all enterprises. Simply stated, we help radiologists see things that others don’t.
ClearRead CT is the first FDA-cleared device to support concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection performance for all nodule types.
Using AI technology, hundreds of traditional CT images are consolidated to create a secondary series that suppresses vessels and other normal structures in the lung to offer an unobstructed view for clinicians.
ClearRead CT is the first FDA-cleared device to support concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection performance for all nodule types.
Using AI technology, hundreds of traditional CT images are consolidated to create a secondary series that suppresses vessels and other normal structures in the lung to offer an unobstructed view for clinicians.
The Riverain Technologies ClearRead Xray platform is comprised of five FDA-cleared applications designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
The solutions optimize the diagnostic value of all portable and upright images. By suppressing bone on digital images, ClearRead Xray increases the visibility of soft tissue in standard chest XRs.
The Riverain Technologies ClearRead Xray platform is comprised of five FDA-cleared applications designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
The solutions optimize the diagnostic value of all portable and upright images. By suppressing bone on digital images, ClearRead Xray increases the visibility of soft tissue in standard chest XRs.
Riverain understands that downtime can be crippling for our clients. For that reason, we promise a well planned and efficiently executed installation by the same team they can rely on for dependable service later. Acquisition normalization technology, along with programmable routing and exam filtering tools, allows rapid installation and site-specific configuration.
ClearRead provides new images into existing software so clinicians can use them in their preferred work environment with very little additional training. Our applications produce adjunctive DICOM images and content that seamlessly interface with the existing facility PACS. The result is a cost-effective, efficient viewing experience for the radiologist.
ClearRead content is read on an institution's existing PACS review station, eliminating the need for costly dedicated workstations and disjointed workflows.
ClearRead content is read on an institution's existing PACS review station, eliminating the need for costly dedicated workstations and disjointed workflows.
As an Installation Project Engineer and PACS Specialist with Riverain Technologies, Charlie Von Eschen understands that our technology should not only break down barriers for radiologists, but for their organizations employing our software as well. Listen to Charlie’s insights into our commitment to ease of installation and follow-up service.
ClearRead AI technology excels in clinical studies.
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
